0001179110-19-011796.txt : 20191118 0001179110-19-011796.hdr.sgml : 20191118 20191118173304 ACCESSION NUMBER: 0001179110-19-011796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191114 FILED AS OF DATE: 20191118 DATE AS OF CHANGE: 20191118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON JOHN CENTRAL INDEX KEY: 0001410781 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37569 FILM NUMBER: 191228492 MAIL ADDRESS: STREET 1: DENDREON CORPORATION STREET 2: 1301 2ND AVENUE CITY: SEATTLE STATE: WA ZIP: 98101 FORMER NAME: FORMER CONFORMED NAME: Johnson John H DATE OF NAME CHANGE: 20070827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 4 1 edgar.xml FORM 4 - X0306 4 2019-11-14 0 0001634432 Strongbridge Biopharma plc SBBP 0001410781 JOHNSON JOHN 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 1 1 0 0 Executive Chairman Employee Stock Option (right to buy) 1.56 2019-11-14 4 A 0 275000 0 A 2029-11-14 Common Stock 275000 275000 D Granted in connection with the Reporting Person's appointment as executive chairman of the Issuer. This option vests in sixteen equal quarterly installments beginning February 14, 2020, provided the Reporting Person is employed by or serving as a director of the Issuer on each vesting date. /s/ Stephen J. Long, as attorney-in-fact 2019-11-18